![Patrice Rioux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrice Rioux
Gründer bei
THIOGENESIS THERAPEUTICS, CORP.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Patrice P.
Rioux is the founder of Thiogenesis Therapeutics, Inc., founded in 2016, holding the titles of President, Chief Executive Officer & Director and Co-President, Chief Executive Officer & Director since 2016.
Dr. Rioux is the founder of Thiogenesis Therapeutics Corp., founded in 2018, holding the title of Chief Executive Officer & Director since 2022.
Dr. Rioux currently serves as Chief Medical Officer at Monopar Therapeutics, Inc. since 2016.
Former positions include Senior Vice President-Global Clinical Development at ArmaGen, Inc., Chief Medical Officer at FerroKin BioSciences, Inc., Chief Medical Officer at Horizon Pharmaceutical LLC, Chief Medical Officer at Raptor Pharmaceuticals Corp.
from 2009 to 2014, Vice President-Medical Research at Repligen Corp.
from 2000 to 2004, and Chief Medical Officer at Edison Pharmaceuticals, Inc. from 2005 to 2007.
Education includes a doctorate from Faculté de Médecine Paris and undergraduate studies at Pitié-Salpêtrière.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.07.2025 | 6 770 069 ( 13,06 % ) | 3 Mio $ | 31.05.2026 | |
MONOPAR THERAPEUTICS INC 0,06 % | 01.01.2026 | 3 687 ( 0,06 % ) | 239 802 $ | 31.05.2026 |
Aktive Positionen von Patrice Rioux
| Unternehmen | Position | Beginn |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2016 |
| THIOGENESIS THERAPEUTICS, CORP. | Gründer | 03.05.2018 |
Thiogenesis Therapeutics, Inc.
 Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Gründer | 01.02.2016 |
Ehemalige bekannte Positionen von Patrice Rioux
| Unternehmen | Position | Ende |
|---|---|---|
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2014 |
Edison Pharmaceuticals, Inc.
 Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2007 |
| REPLIGEN CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Corporate Officer/Principal | - |
| RAPTOR PHARMACEUTICAL CORP | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Patrice Rioux
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Health Technology |
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
 Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Faculté de Médecine Paris
 Faculté de Médecine Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thiogenesis Therapeutics, Inc.
Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pitié-Salpêtrière
 Pitié-Salpêtrière Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
